Disorders of the Immune System in Pregnancy
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: 20 June 2024 | Viewed by 2262
Special Issue Editors
Interests: fetal growth restriction; intrapartum ultrasound; parental diagnosis; maternal–fetal medicine; placenta accreta spectrum; fetal cardiac function
Interests: intrapartum ultrasound; maternal–fetal medicine; prenatal diagnosis; fetal growth restriction; placenta accreta spectrum; fetal cardiac function; intrapartum fetal monitoring
Special Issue Information
Dear Colleagues,
Pregnancy is characterized by a unique immunological environment characterized by the suppression of a variety of cell- and antibody-mediated mechanisms to accommodate the fetus and allow pregnancy continuation. This may explain the remission of some autoimmune disorders during pregnancy and also the increased incidence of complications in women with active disease at the time of conception or disease upturn at any point of gestation. Almost all organs and systems can be affected, and several pregnancy-specific complications can occur in pregnant women with autoimmune disease. The fetus is not exempt given that the transplacental passage of maternal auto- and alloantibodies may be responsible for the damage of fetal tissues and cells such as erythrocytes and platelets.
The aim of this Special Issue is to present novel and high-quality research in the field and highlight the most up-to-date evidence in the context of diagnosis, management, and prognosis of various disorders of the immune system, potentially leading to maternal and fetal complications during pregnancy.
Prof. Dr. Andrea Dall'Asta
Prof. Dr. Tullio Ghi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fetal alloimmunization
- antiplatelet alloantibodies
- congenital heart block
- celiac disease in pregnancy
- anti-cardiolipin antibodies in pregnancy
- anti-beta2 microglobulin antibodies in pregnancy
- renal autoimmunity in pregnancy
- IBD in pregnancy
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Pre-conceptional counselling in women with autoimmune inflammatory rheumatic diseases
Abstract:
Rheumatic diseases in pregnancy represent a complex challenge for both patients and healthcare providers. Timely and interdisciplinary preparation for pregnancy focusing on adequate disease control may reduce the risk of disease flare and the overall risk of maternal and fetal pregnancy complications. This review provides a comprehensive overview of the essential components of pre-pregnancy counselling in rheumatic disease, including medication management strategies tailored to pregnant individuals, disease activity monitoring throughout pregnancy, maternal and fetal pregnancy monitoring in rheumatic disease and the promotion of shared decision-making between healthcare providers and patients. Guidelines from key international organizations will be critically assessed and discussed, highlighting the quintessential discussion points of care in this special group of patients.
Keywords: pre-pregnancy counselling; rheumatic diseases; interdisciplinary care; disease control; fetal and maternal obstetric complications